Syndax Pharmaceuticals
SNDX
SNDX
121 hedge funds and large institutions have $1.02B invested in Syndax Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 48 increasing their positions, 36 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0.97% less ownership
Funds ownership: 99.19% → 98.21% (-0.97%)
11% less funds holding
Funds holding: 136 → 121 (-15)
46% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 24
Holders
121
Holding in Top 10
6
Calls
$3.85M
Puts
$381K
Top Buyers
| 1 | +$26.4M | |
| 2 | +$21.4M | |
| 3 | +$19.1M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$12.1M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$11.1M |
Top Sellers
| 1 | -$28.1M | |
| 2 | -$20.2M | |
| 3 | -$8.43M | |
| 4 |
Morgan Stanley
New York
|
-$7.81M |
| 5 |
Millennium Management
New York
|
-$7.72M |